New imaging technology to visualize DNA at a very small scale
Intrinsic-contrast super-resolution imaging of DNA at 2-nm resolution
['FUNDING_R01'] · NORTHWESTERN UNIVERSITY · NIH-10691266
This study is testing a new imaging technology that can take super-detailed pictures of cells without using any dyes, which could help doctors better understand diseases and improve how they diagnose and treat patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-10691266 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel imaging technology called spectroscopic intrinsic-contrast photon-localization optical nanoscopy (SICLON) that allows for label-free imaging of cellular structures at an unprecedented resolution of 2 nanometers. By utilizing a unique physical effect that enables biopolymers like DNA to exhibit fluorescence under specific light conditions, this approach aims to provide detailed insights into the three-dimensional architecture and molecular composition of cells. Patients may benefit from advancements in understanding cellular processes and diseases through improved imaging techniques that could lead to better diagnostics and treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with genetic disorders or diseases that affect cellular function.
Not a fit: Patients with conditions unrelated to cellular structure or function may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking advancements in how we visualize and understand cellular functions, potentially improving disease diagnosis and treatment.
How similar studies have performed: Other research has shown success with advanced imaging techniques, but this specific approach using SICLON is novel and untested.
Where this research is happening
Chicago, UNITED STATES
- NORTHWESTERN UNIVERSITY — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHANG, HAO F — NORTHWESTERN UNIVERSITY
- Study coordinator: ZHANG, HAO F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.